+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latent AMR Market - Global Forecast 2025-2030- Product Image
Latent AMR Market - Global Forecast 2025-2030- Product Image
Sale

Latent AMR Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6144640
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antimicrobial resistance market is undergoing rapid transformation as emerging diagnostic technologies, changing global regulations, and intensified collaboration across industry sectors reshape competitive strategies. Senior decision-makers require clear, actionable insight to navigate the layered complexities and proactively address latent resistance challenges.

Market Snapshot: Antimicrobial Resistance Market

The global antimicrobial resistance landscape is advancing at an unprecedented pace, as resilient pathogens and evolving resistance mechanisms increase clinical and economic pressure. Stakeholders face tightening margins and must integrate novel genomic and phenotypic approaches to remain competitive. Investment activity is strong behind laboratory networks and biotechnology startups, while public health programs and regulatory agencies prioritize adaptive diagnostic frameworks. Industry leaders are recalibrating their sourcing, manufacturing, and partnership models to drive more agile response strategies across all geographies.

Scope & Segmentation

This report delivers a comprehensive, structured analysis of antimicrobial resistance, spanning technology, product portfolios, applications, end users, pathogen types, and laboratory workflows. The regional focus covers the Americas, Europe, Middle East & Africa, and Asia Pacific, reflecting market variations and the reach of ecosystem participants.

  • Technologies: Genotypic (including microarray, next-generation sequencing, and PCR), and phenotypic (automated systems, broth microdilution, disc diffusion).
  • Products: Instruments, kits and reagents, and software and services—such as consulting, data analysis software, and laboratory information management systems (LIMS).
  • Applications: Diagnostics (clinical and research), drug discovery and development, surveillance programs.
  • End Users: Hospitals and clinics, pharmaceutical companies, reference laboratories, and research institutes.
  • Pathogens: Bacterial, fungal, parasitic, and viral resistance detection.
  • Workflow Stages: Pre-analytical, analytical, and post-analytical phases.
  • Geographies: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Scandinavian and Middle Eastern countries), and Asia Pacific (with leadership by China, India, Japan, Australia, Southeast Asia).
  • Leading Companies: Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Siemens Healthineers AG, Danaher Corporation, QIAGEN N.V., Hologic, Inc., Illumina, Inc.

Key Takeaways

  • Widespread adoption of genomic and phenotypic diagnostic tools is exposing previously undetectable resistance markers, prompting a rethink in laboratory and clinical practice.
  • Cross-sector alliances between research institutions, diagnostics developers, and public health agencies enable deeper data integration, driving real-time surveillance and predictive stewardship strategies.
  • Industry players increasingly invest in modular assay design and domestic manufacturing to safeguard operations and streamline adaptation to supply chain disruptions.
  • Market regionalization is shaping product demand and innovation cycles: the Americas lead in clinical infrastructure, EMEA in regulatory harmonization, and Asia Pacific in digital platform integration and local manufacturing.
  • Integrated software and consulting services are elevating value delivery beyond instrumentation, supporting end-to-end workflows and compliance with shifting regulatory standards.

Tariff Impact on the Antimicrobial Resistance Market

United States tariff policies have significantly increased costs for key reagents and laboratory instruments, prompting organizations to improve procurement diversification and consider domestic alternatives. Diagnostic developers are favoring modular assay designs to enable flexible reagent substitution with minimal revalidation. Supply chain strategies now include renegotiated contracts and investment in local manufacturing, reinforcing industry resilience amid regulatory unpredictability.

Methodology & Data Sources

This analysis applies a blend of primary and secondary research techniques, including expert interviews, peer-reviewed literature, and regulatory filings. Data triangulation and benchmarking studies ensure robust and consistent findings, validated by expert panels and multi-disciplinary reviews.

Why This Report Matters

  • Enables senior leaders to anticipate emerging antimicrobial resistance trends and optimize investment decisions across technology, sourcing, and strategy.
  • Supports agile responses to regulatory shifts, supply chain risks, and competitive threats through actionable segmentation and market analysis.
  • Provides evidence-based guidance for aligning diagnostic innovation with evolving public health and clinical objectives.

Conclusion

Effective antimicrobial resistance management calls for technology-driven adaptation, resilient sourcing, and global coordination. This comprehensive report equips decision-makers with the critical insights needed to confidently address rising resistance challenges in dynamic market contexts.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising investment in bacteriophage therapy platforms targeting multidrug resistant infections
5.2. Integration of rapid point of care diagnostic tools to curb inappropriate antibiotic use
5.3. Emergence of antimicrobial stewardship programs integrated with electronic health record data analytics
5.4. Growing consumer demand for antibiotic free and sustainably sourced protein products in retail markets
5.5. Advancements in CRISPR based antimicrobials offering targeted pathogen elimination with minimal microbiome disruption
5.6. Surge in regulatory incentives and government grants accelerating development of novel antibiotic classes globally
5.7. Increasing adoption of artificial intelligence algorithms for predicting resistance patterns and optimizing treatment regimens
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Latent AMR Market, by Technology
8.1. Introduction
8.2. Genotypic
8.2.1. Microarray
8.2.2. Ngs
8.2.3. Pcr
8.3. Phenotypic
8.3.1. Automated Systems
8.3.2. Broth Microdilution
8.3.3. Disc Diffusion
9. Latent AMR Market, by Product
9.1. Introduction
9.2. Instruments
9.3. Kits & Reagents
9.4. Software & Services
9.4.1. Consulting Services
9.4.2. Data Analysis Software
9.4.3. Lims
10. Latent AMR Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Clinical
10.2.2. Research
10.3. Drug Discovery & Development
10.4. Surveillance
11. Latent AMR Market, by End User
11.1. Introduction
11.2. Hospitals & Clinics
11.3. Pharmaceutical Companies
11.4. Reference Laboratories
11.5. Research Institutes
12. Latent AMR Market, by Pathogen
12.1. Introduction
12.2. Bacterial
12.3. Fungal
12.4. Parasitic
12.5. Viral
13. Latent AMR Market, by Workflow
13.1. Introduction
13.2. Analytical
13.3. Post Analytical
13.4. Pre Analytical
14. Americas Latent AMR Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Latent AMR Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Latent AMR Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Roche Diagnostics International AG
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Abbott Laboratories
17.3.4. Becton, Dickinson and Company
17.3.5. bioMérieux SA
17.3.6. Siemens Healthineers AG
17.3.7. Danaher Corporation
17.3.8. QIAGEN N.V.
17.3.9. Hologic, Inc.
17.3.10. Illumina, Inc.
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. LATENT AMR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LATENT AMR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LATENT AMR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LATENT AMR MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LATENT AMR MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LATENT AMR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LATENT AMR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LATENT AMR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LATENT AMR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LATENT AMR MARKET SIZE, BY PATHOGEN, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LATENT AMR MARKET SIZE, BY PATHOGEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LATENT AMR MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LATENT AMR MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LATENT AMR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LATENT AMR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LATENT AMR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LATENT AMR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LATENT AMR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LATENT AMR MARKET: RESEARCHAI
FIGURE 28. LATENT AMR MARKET: RESEARCHSTATISTICS
FIGURE 29. LATENT AMR MARKET: RESEARCHCONTACTS
FIGURE 30. LATENT AMR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LATENT AMR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LATENT AMR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LATENT AMR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LATENT AMR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LATENT AMR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LATENT AMR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LATENT AMR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LATENT AMR MARKET SIZE, BY GENOTYPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LATENT AMR MARKET SIZE, BY GENOTYPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LATENT AMR MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LATENT AMR MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LATENT AMR MARKET SIZE, BY NGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LATENT AMR MARKET SIZE, BY NGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LATENT AMR MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LATENT AMR MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LATENT AMR MARKET SIZE, BY PHENOTYPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LATENT AMR MARKET SIZE, BY PHENOTYPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LATENT AMR MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LATENT AMR MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LATENT AMR MARKET SIZE, BY BROTH MICRODILUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LATENT AMR MARKET SIZE, BY BROTH MICRODILUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LATENT AMR MARKET SIZE, BY DISC DIFFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LATENT AMR MARKET SIZE, BY DISC DIFFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LATENT AMR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LATENT AMR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LATENT AMR MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LATENT AMR MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LATENT AMR MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LATENT AMR MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LATENT AMR MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LATENT AMR MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LATENT AMR MARKET SIZE, BY LIMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LATENT AMR MARKET SIZE, BY LIMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LATENT AMR MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LATENT AMR MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LATENT AMR MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LATENT AMR MARKET SIZE, BY CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LATENT AMR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LATENT AMR MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LATENT AMR MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LATENT AMR MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LATENT AMR MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LATENT AMR MARKET SIZE, BY SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LATENT AMR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LATENT AMR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LATENT AMR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LATENT AMR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LATENT AMR MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LATENT AMR MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LATENT AMR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LATENT AMR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LATENT AMR MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LATENT AMR MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LATENT AMR MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LATENT AMR MARKET SIZE, BY FUNGAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LATENT AMR MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LATENT AMR MARKET SIZE, BY PARASITIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LATENT AMR MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LATENT AMR MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LATENT AMR MARKET SIZE, BY ANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LATENT AMR MARKET SIZE, BY ANALYTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LATENT AMR MARKET SIZE, BY POST ANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LATENT AMR MARKET SIZE, BY POST ANALYTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LATENT AMR MARKET SIZE, BY PRE ANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LATENT AMR MARKET SIZE, BY PRE ANALYTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LATENT AMR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LATENT AMR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LATENT AMR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LATENT AMR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 133. CANADA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. CANADA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. CANADA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 136. CANADA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 137. CANADA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 138. CANADA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 139. CANADA LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. CANADA LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. CANADA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 142. CANADA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 143. CANADA LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 146. CANADA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 147. CANADA LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 150. CANADA LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 151. CANADA LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 152. CANADA LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 153. MEXICO LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 156. MEXICO LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 157. MEXICO LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 158. MEXICO LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 159. MEXICO LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. MEXICO LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. MEXICO LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 162. MEXICO LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 170. MEXICO LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 171. MEXICO LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 172. MEXICO LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA LATENT AMR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 255. GERMANY LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 258. GERMANY LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 259. GERMANY LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 260. GERMANY LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 261. GERMANY LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 262. GERMANY LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 263. GERMANY LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 264. GERMANY LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 265. GERMANY LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. GERMANY LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. GERMANY LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. GERMANY LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 272. GERMANY LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 273. GERMANY LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 274. GERMANY LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 275. FRANCE LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. FRANCE LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 278. FRANCE LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 279. FRANCE LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 280. FRANCE LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 281. FRANCE LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. FRANCE LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. FRANCE LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 284. FRANCE LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 285. FRANCE LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. FRANCE LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. FRANCE LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 292. FRANCE LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 293. FRANCE LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 294. FRANCE LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 315. ITALY LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. ITALY LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. ITALY LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 318. ITALY LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 319. ITALY LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 320. ITALY LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 321. ITALY LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 322. ITALY LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 323. ITALY LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 324. ITALY LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 325. ITALY LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. ITALY LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. ITALY LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 328. ITALY LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 329. ITALY LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. ITALY LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. ITALY LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 332. ITALY LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 333. ITALY LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 334. ITALY LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 335. SPAIN LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 336. SPAIN LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 337. SPAIN LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 338. SPAIN LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 339. SPAIN LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 340. SPAIN LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 341. SPAIN LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 342. SPAIN LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 343. SPAIN LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 344. SPAIN LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 345. SPAIN LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 346. SPAIN LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 347. SPAIN LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 348. SPAIN LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 349. SPAIN LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. SPAIN LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. SPAIN LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 352. SPAIN LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 353. SPAIN LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 354. SPAIN LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 368. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 369. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 370. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 371. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY PATHOGEN, 2018-2024 (USD MILLION)
TABLE 372. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY PATHOGEN, 2025-2030 (USD MILLION)
TABLE 373. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 374. UNITED ARAB EMIRATES LATENT AMR MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 375. SAUDI ARABIA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 376. SAUDI ARABIA LATENT AMR MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 377. SAUDI ARABIA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2018-2024 (USD MILLION)
TABLE 378. SAUDI ARABIA LATENT AMR MARKET SIZE, BY GENOTYPIC, 2025-2030 (USD MILLION)
TABLE 379. SAUDI ARABIA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2018-2024 (USD MILLION)
TABLE 380. SAUDI ARABIA LATENT AMR MARKET SIZE, BY PHENOTYPIC, 2025-2030 (USD MILLION)
TABLE 381. SAUDI ARABIA LATENT AMR MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 382. SAUDI ARABIA LATENT AMR MARKET SIZE, BY PR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Latent AMR Market report include:
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Siemens Healthineers AG
  • Danaher Corporation
  • QIAGEN N.V.
  • Hologic, Inc.
  • Illumina, Inc.

Related Reports

Latent 5G AMR Market - Global Forecast 2025-2030 - Product Image

Latent 5G AMR Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Latent Jacking AGVs & AMRs Market - Global Forecast 2025-2030 - Product Image

Latent Jacking AGVs & AMRs Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market, Global, 2024-2030 - Product Image

Antimicrobial Resistance Diagnostics Market, Global, 2024-2030

  • Report
  • Global
From
Antimicrobial Resistance Diagnostics - Global Strategic Business Report - Product Image

Antimicrobial Resistance Diagnostics - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Autonomous Mobile Robots Market Size, Share & Trends Analysis Report by Component, Type, Battery, Application, Payload Capacity, End-use, Navigation Technology, and Region with Growth Forecasts, 2025-2030 - Product Image

Autonomous Mobile Robots Market Size, Share & Trends Analysis Report by Component, Type, Battery, Application, Payload Capacity, End-use, Navigation Technology, and Region with Growth Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.